Breaking Down the Common Technical Document (CTD): Where Does Regulatory Writing Fit?

The Common Technical Document (CTD) is the foundation of regulatory submissions worldwide. While many view it as a collection of documents, regulators see it as one integrated story supporting a product’s quality, safety, and efficacy. That’s where strategic regulatory writing makes all the difference.

At Med Communications, we help pharmaceutical and biotechnology companies transform complex data into clear, consistent, submission-ready content across the CTD.

📂 Module 1: Regional Information
Administrative forms, labeling, and region-specific requirements.
🟦 Our role: Investigator’s Brochures and updates, General Investigational Plans, and briefing books writing support.

📂 Module 2: Summaries & Overviews
The strategic core of the CTD that translates data into a compelling regulatory narrative.
🟦 Our role: Authoring Clinical Overviews and Summaries, Nonclinical Overviews and Summaries, and the Quality Overall Summary, while ensuring consistency across the entire dossier.

📂 Module 3: Quality (CMC)
The overall body of data supporting the commercial drug substance and drug product including their identification and composition, development, manufacture, control, packaging, and stability to ensure consistent product quality.
🟦 Our role: Content development across all Module 3 sections, including cross-functional coordination, document integration, compliance with regional health authority requirements, quality control, and life cycle management.

📂 Module 4: Nonclinical Reports
Pharmacology, pharmacokinetics, and toxicology data.

📂 Module 5: Clinical Reports
Clinical evidence supporting safety and efficacy.
🟦 Our role: Protocols, Investigator’s Brochures, clinical study reports, and integrated summaries.

The most successful submissions aren’t just complete; they’re consistent. When messaging, data interpretation, and scientific rationale align across modules, regulators can review submissions more efficiently and confidently. At Med Communications, we help sponsors build that consistency from early development through submission.

Preparing an IND, CTA, NDA, BLA, or MAA? Let’s connect to discuss how our regulatory writing experts can help strengthen your CTD and accelerate submission readiness.
📞 877-477-0977
🌐 https://medcommunications.com/contact-us/